EFFICACY, SAFETY AND IMMUNOGENICITY FROM WEEK 30 TO WEEK 54 IN A RANDOMISED, DOUBLE-BLIND PHASE III STUDY COMPARING A PROPOSED INFLIXIMAB BIOSIMILAR (PF-06438179/GP1111) WITH REFERENCE INFLIXIMAB
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F18%3A43876872" target="_blank" >RIV/62157124:16370/18:43876872 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1136/annrheumdis-2018-eular.5121" target="_blank" >http://dx.doi.org/10.1136/annrheumdis-2018-eular.5121</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1136/annrheumdis-2018-eular.5121" target="_blank" >10.1136/annrheumdis-2018-eular.5121</a>
Alternative languages
Result language
angličtina
Original language name
EFFICACY, SAFETY AND IMMUNOGENICITY FROM WEEK 30 TO WEEK 54 IN A RANDOMISED, DOUBLE-BLIND PHASE III STUDY COMPARING A PROPOSED INFLIXIMAB BIOSIMILAR (PF-06438179/GP1111) WITH REFERENCE INFLIXIMAB
Original language description
PF-06438179/GP1111 (GP1111) is an infliximab (IFX) biosimilar in development for the treatment of immune-mediated inflammatory diseases, including rheumatoid arthritis (RA). The efficacy, safety and immunogenicity of GP1111 and European reference IFX (IFX-EU) have been reported to be similar over 30 weeks (Wks). Results from TP2 (Wks 30?54) continued to show the absence of clinically meaningful differences in efficacy, safety and immunogenicity between patients with RA remaining on GP1111 or IFX-EU, or when blindly switched from IFX-EU to GP1111
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Annals of the rheumatic diseases
ISSN
0003-4967
e-ISSN
—
Volume of the periodical
77
Issue of the periodical within the volume
červen
Country of publishing house
GB - UNITED KINGDOM
Number of pages
2
Pages from-to
612-613
UT code for WoS article
000444351001599
EID of the result in the Scopus database
—